Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib–hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis
- 17 February 2022
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 172, 203-212
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in miceNanotechnology, 2012
- Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicityXenobiotica, 2011
- Formulation of rifampicin–cyclodextrin complexes for lung nebulizationJournal of Controlled Release, 2008
- Effects of Cyclodextrins on Drug Delivery Through Biological MembranesJournal of Pharmaceutical Sciences, 2007
- Precipitation Complexation Method Produces Cannabidiol/β-Cyclodextrin Inclusion Complex Suitable for Sublingual Administration of CannabidiolJournal of Pharmaceutical Sciences, 2007
- β-cyclodextrin complexes of celecoxib: Molecular-modeling, characterization, and dissolution studiesAAPS PharmSci, 2004
- Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrinInternational Journal of Pharmaceutics, 2002
- Preliminary Safety Evaluation of Parenterally Administered Sulfoalkyl Ether β-Cyclodextrin DerivativesJournal of Pharmaceutical Sciences, 1995
- Hydroxypropylcyclodextrins in Parenteral use. I: Lipid Dissolution and Effects on Lipid Transfers in VitroJournal of Pharmaceutical Sciences, 1992
- Differential effects of α‐, β‐ and γ‐cyclodextrins on human erythrocytesEuropean Journal of Biochemistry, 1989